Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus
Crossref DOI link: https://doi.org/10.1007/s00431-017-2926-8
Published Online: 2017-05-16
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Buchs, Clélia
Dalphin, Marie-Laure
Sanchez, Stéphane
Perceval, Marie
Coutier, Laurianne
Mainguy, Catherine
Kassaï-Koupaï, Behrouz
Reix, Philippe
License valid from 2017-05-16